Report #2832434

Received Mar 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 13 yrs
State: IL
Recovered: Unknown
Vaccinated: Nov 14, 2019
Onset: —
Days to onset: —
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	1	—	OT
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	2	—	OT

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

Inbound call from HCP asking about continuing GARDASIL 9 series after the 3rd dose is late. 1st dose 11/14/2019, 2nd dose 7/8/2020 (see request case 02761318). No adverse effects were reported. Unknown Lots and Expiration dates. Caller did not provid; No adverse effects were reported; This spontaneous report was received from a pharmacist and refers to a current 18-year-old female patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 14-NOV-2019, the patient was vaccinated with the first dose of human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) (strength, exact dose, route of administration, anatomical location, lot #, and expiration date were not reported). Then on 08-JUL-2020, the patient received the second dose of the suspect vaccine (as described above). Both administered as prophylaxis. Therefore, the third dose was late (inappropriate schedule of vaccine administered). No adverse effects were reported (no adverse event).